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In previous studies of tap water consumption
conducted in California by the Department of
Health Services, we reported a 10–50% in-
creased risk of spontaneous abortion with tap
versus bottled water consumption (Neutra et al.
1992; Swan et al. 1992; Windham et al. 1992).
To investigate these findings further, we initi-
ated several studies that included a large
prospective study of pregnancy outcome in
three regions of California. Because of increased
concern about the health effects of chlorination
by-products, in the follow-up we examined
pregnancy outcome by trihalomethane (THM)
levels, the most prevalent class of such by-prod-
ucts measured quarterly by the water utility
companies. In that study, women with high
consumption of tap water (≥ 5 glasses/day) con-
taining high levels of total trihalomethanes
(TTHM) (≥ 75 µg/L) had an increased odds of
spontaneous abortion on the order of 80%
(Waller et al. 1998a, 2001). Some other studies
have examined risks of spontaneous abortion,
stillbirth, birth defects, or fetal growth retarda-
tion in relation to water chlorination by-prod-
ucts, with varying results. Although the
epidemiological studies are limited, together
they suggest a slightly increased risk of adverse
reproductive and pregnancy outcomes (Bove et
al. 1995; Dodds and King 2001; Dodds et al.
1999; Gallagher et al. 1998; King et al. 2000;
Klotz and Pyrch 1999; Kramer et al. 1992;
Savitz et al. 1995) that should be examined
further (Nieuwenhuijsen et al. 2000).
One recommendation has been to study
female reproductive function, including
fecundity and menstruation (Reif et al.
1996). The menstrual cycle appears to influ-
ence important aspects of women’s physio-
logic function, yet studies of determinants of
menstrual function, including environmental
risk factors, are lacking (Harlow and Ephross
1995). Therefore, to determine whether
THMs are associated with other reproductive
end points and to identify possible mecha-
nisms, we examined data from our second
follow-up study. This Women’s Reproductive
Health Study was a prospective study de-
signed to examine a number of exposures in
relation to early fetal loss, time to pregnancy,
and menstrual function among reproductive-
age women. These included tap water con-
sumption, smoking, and solvents. This report
is the first, to our knowledge, to examine
menstrual cycle function in relation to THM
levels and tap water consumption; another
report will examine time to pregnancy in
these data.
Materials and Methods
The data collection and analytic methods for
the Women’s Reproductive Health Study is
described in detail elsewhere (Waller et al.
1998b; Windham et al. 2002) and sum-
marized below. The study protocol was
approved by the institutional review boards of
both Kaiser Permanente and the California
Department of Health Services, and the par-
ticipants provided written consent.
Married women of reproductive age
(18–39 years old) who were members of the
Kaiser Permanente Medical Care Program in
Northern California and attended clinic facili-
ties in the same region as our earliest water
studies were the target population. Almost
6,500 were screened by a short telephone
interview to identify women who were more
likely to become pregnant (a menstrual period
within past 6 weeks, no surgical sterilization,
not currently using birth control pills or
intrauterine devices, or noncontracepting less
than 3 months) and willing to collect and
freeze first morning urine samples daily for 6
months or until they became pregnant.
Participants were enlisted between May 1990
and June 1991. Of the 1,092 eligible women
identified, 553 agreed to participate, but 89
dropped out during urine collection and 61
became ineligible (e.g., because of moving,
early pregnancy, starting birth control pills),
leaving 403 women who collected urine dur-
ing 2–9 menstrual cycles (average 5.6). Before
urine collection, participants completed a
detailed baseline interview by telephone that
asked about their water consumption and
numerous potential confounders. Women
filled out a daily diary during urine collection
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We analyzed data from a prospective study of menstrual cycle function and early pregnancy loss to
explore further the effects of trihalomethanes (THM) on reproductive end points. Premenopausal
women (n = 403) collected urine samples daily during an average of 5.6 cycles for measurement of
steroid metabolites that were used to define menstrual parameters such as cycle and phase length.
Women were asked about consumption of various types of water as well as other habits and demo-
graphics. A THM level was estimated for each cycle based on residence and quarterly measure-
ments made by water utilities during a 90-day period beginning 60 days before the cycle start
date. We found a monotonic decrease in mean cycle length with increasing total THM (TTHM)
level; at > 60 µg/L, the adjusted decrement was 1.1 days [95% confidence interval (CI), –1.8 to
–0.40], compared with ≤ 40 µg/L. This finding was also reflected as a reduced follicular phase
length (difference –0.94 day; 95% CI, –1.6 to –0.24). A decrement in cycle and follicular phase
length of 0.18 days (95% CI, –0.29 to –0.07) per 10 µg/L unit increase in TTHM concentration
was found. There was little association with luteal phase length, menses length, or cycle variabil-
ity. Examining the individual THMs by quartile, we found the greatest association with chloro-
dibromomethane or the sum of the brominated compounds. Incorporating tap water consumption
showed a similar pattern of reduced cycle length with increasing TTHM exposure. These findings
suggest that THM exposure may affect ovarian function and should be confirmed in other studies.
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to record vaginal bleeding (number of pads or
tampons/day), among other items.
Definition of menstrual characteristics.
Daily urine samples were analyzed for metabo-
lites of estrogen (estrone conjugates) and prog-
esterone (pregnanediol-3-glucuronide) by
enzyme-linked immunoassay and adjusted for
creatinine as previously reported (Munro et al.
1991; Waller et al. 1998b; Windham et al.
2002). We defined menstrual cycles by bleed-
ing patterns. Determination of ovulatory sta-
tus was based on observing a sufficient relative
rise in progesterone over baseline levels
(Kassam et al. 1996; Waller et al. 1998b). The
day of ovulation was estimated using a previ-
ously validated algorithm that generally selects
the day after the peak of the estrogen to prog-
esterone ratio (Baird et al. 1990; Waller et al.
1998b). Steroid assays were repeated in cycles
that were nonovulatory or had a late day of
ovulation (n = 533); in 46% of these the
abnormality was confirmed, whereas in 54%
we used the more normal reassay results to be
conservative. Steroid levels were also examined
graphically, and in a small proportion of cycles
(5.6%), we recoded the day of ovulation to
better correspond to the steroid patterns. All
hormone assessments were conducted blinded
to TTHM level.
We calculated cycle length from the first
day of menses to the day before the onset of the
next menses. The cycle was divided into the fol-
licular phase, from the first day of menses
through the estimated day of ovulation, and the
subsequent luteal phase, where possible. We
examined mean cycle and phase lengths as well
as categorizing them based on the 5th and 95th
percentiles of their distributions to define short
and long cycles, respectively. Thus the lengths
of average or normal cycles, follicular phases,
and luteal phases (e.g., referent groups) were
25–35 days, 12–23 days, and 11–14 days,
respectively. Bleed, or menses, length was the
number of consecutive days of reported pad
use, with 8 or more days considered long.
Urine collection did not necessarily begin or
end on menses dates, so not all end points
could be calculated for each cycle; 1,624 cycles
were available for cycle length analyses, 1,514
for follicular phase, 1,424 for luteal phase, and
1,714 for menses analyses. We also examined
continuous measures of cycle length variability.
Variability was calculated as both a range, or
the difference between a woman’s longest and
shortest cycle lengths, and as the variance across
a woman’s cycle lengths, for women with at
least two complete cycles (n = 375).
Exposure assessment. During the baseline
interview, women were asked the amount (in
8-ounce glasses) of usual daily consumption
of unheated tap water (or drinks made from
unheated tap water) at home, drinks made
with hot tap water at home, and bottled
water. The number of showers taken per week
at home and their duration was also ascer-
tained, from which we calculated minutes of
showering per week.
We estimated TTHM levels in tap water in
a manner similar to our previous prospective
study, which was based on an average of all
measurements taken by a utility (e.g., utility-
wide average) (Waller et al. 1998a, 2001). The
subjects’ addresses during the study were
geocoded and then assigned to one of the 10
appropriate water utility companies in the
county. We obtained quarterly monitoring data
of THM levels collected at various points
(range 4–20, average 9) in the distribution sys-
tem from each utility. We summed the individ-
ual THM compounds to calculate TTHMs
and used that data to estimate the TTHM con-
centration in each woman’s home tap water for
each of her cycles. Because water utilities col-
lected THM data at roughly 90-day intervals,
we assigned a 90-day exposure time period for
each cycle. As hormonal events that occur in
previous cycles can influence subsequent cycles,
we selected the time period of 60 days before to
30 days after each cycle start date. Cycle-specific
TTHM levels were thus calculated by averaging
all distribution system TTHM measurements
taken by the subject’s utility company during
this 90-day window. If no water samples were
taken during the window, the samples closest in
time to either end of the window were aver-
aged. If a woman had moved during the time
period, the utility measures for each address
were calculated, then averaged, weighting by
the proportion of time spent at each address.
We also averaged a woman’s cycle-specific
TTHM measures to obtain an estimate of
her average exposure during urine collection.
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Table 1. Distribution of demographic variables and potential confounders by TTHM level,a California
Women’s Reproductive Health Study, 1990–1992. 
Total THM level (µg/L)
0–40 > 40–60 > 60–80 > 80
Variable n = 184 (46%)b n = 71 (18%) n = 134 (33%) n = 12 (3%) p-Valuec
Education
No college 41 (46) 11 (12) 34 (38) 3 (3)
Some college 79 (52) 25 (17) 44 (29) 3 (2)
College graduate 64 (40) 35 (22) 56 (35) 6 (4) 0.22d
Race
Hispanic 25 (48) 7 (13) 18 (35) 2 (4)
White 140 (49) 46 (16) 89 (31) 8 (3)
Other 19 (29) 18 (27) 27 (41) 2 (3) 0.09
Income/year
≤ $35,000 41 (68) 9 (15) 7 (12) 3 (5)
> $35,000–$55,000 76 (48) 19 (12) 59 (38) 3 (2)
> $55,000–$75,000 35 (34) 25 (24) 42 (40) 2 (2)
≥ $75,000 28 (40) 16 (23) 22 (31) 4 (6) < 0.001d
Employed
Yes 126 (46) 43 (16) 97 (35) 9 (3)
No 58 (46) 28 (22) 37 (29) 3 (2) 0.35
Pregnancy history
0 Pregnancies 25 (52) 7 (15) 14 (29) 2 (4)
≥ 1 Pregnancies, 0 losses 106 (41) 48 (19) 96 (37) 6 (2)
≥ 1 Pregnancies, ≥ 1 losses 53 (55) 16 (16) 24 (25) 4 (4) 0.21
BMI (kg/m2)
< 19.1 13 (43) 5 (17) 11 (37) 1 (3)
19.1–27.3 129 (44) 54 (19) 99 (34) 9 (3)
> 27.3 42 (53) 12 (15) 24 (30) 2 (2) 0.93
Age (years)
Mean ± SD 31.7 ± 4.1 31.0 ± 4.0 32.4 ± 4.1 32.4 ± 5.2 0.12
Smoking (cigarettes/day)
Mean ± SD 1.4 ± 5.0 1.3 ± 4.2 0.4 ± 2.9 2.7 ± 6.1 0.12
Alcohol (drinks/week)
Mean ± SD 1.3 ± 2.5 2.5 ± 5.4 1.3 ± 2.5 2.2 ± 3.4 0.04
Caffeine (mg/day)
Mean ± SD 137.8 ± 156.8 115.3 ± 127.6 126.1 ± 180.9 233.8 ± 235.8 0.12
Unheated tap water (glasses/day)
Mean ± SD 2.1 ± 2.7 2.4 ± 2.5 2.5 ± 3.0 2.6 ± 2.5 0.66
Heated water (glasses/day)
Mean ± SD 1.1 ± 1.9 1.1 ± 1.6 1.0 ± 1.7 1.8 ± 2.1 0.48
Showering (minutes/week)
Mean ± SD 66.7 ± 40.4 65.7 ± 39.5 65.2 ± 36.2 61.3 ± 25.1 0.97
Exercise score
Mean ± SD 17.9 ± 23.9 17.2 ± 19.9 17.9 ± 23.7 26.5 ± 36.0 0.65
aEach woman’s cycle-specific TTHM measurements are averaged, and the average value is used; cycle-specific mea-
sures are based on an exposure window: 60 days before the last menstrual period to 30 days after the last menstrual
period of each cycle. bNumbers may not add up to column totals because of missing values. cp-Value is for chi-square
test of independence for categorical analyses, and for continuous analyses represents a test of H0; all TTHM categories
have the same mean unless otherwise specified. dp-Value for Fisher’s exact test.
We calculated cycle-specific levels for each of
the four individual THM compounds (bromo-
form, chloroform, chlorodibromomethane, and
bromodichloromethane) in a similar way. As
the brominated compounds were highly corre-
lated, we also examined the sum of the levels of
the three brominated THMs.
Two ingestion metrics were calculated by
multiplying the estimated cycle-specific
TTHM level by the usual number of glasses
of tap water consumed daily at home. We cal-
culated the first using only unheated tap
water, and for the second we used the sum of
unheated and heated tap water. We converted
reported glasses of water to an estimate of
0.25 L per 8-ounce glass to calculate an inges-
tion dose in units of micrograms per day.
We primarily examined exposure levels
as categorical variables. The current U.S.
Environmental Protection Agency (U.S.
EPA) maximum contaminant level (MCL)
for TTHM is > 80 µg/L, so initially we used
that as the cutoff for the highest category.
However, because of small numbers exposed
at that level, we also examined and generally
report > 60 µg/L as the high category (approx-
imately the top quartile). Because there are
currently no MCLs for the individual THM
compounds, we categorized those by quartiles.
The highest category of the ingestion metric
(> 60 µg/day) represents consuming approxi-
mately three glasses of water per day contain-
ing > 80 µg/L TTHM (or equivalently, four
glasses of water with > 60 µg/L TTHM). We
examined showering as both minutes per week
and incorporating the cycle-specific TTHM
level to create combinations of low and high
exposure (low showering as 0–34 min/week
and high as 70 min or more; low TTHM as
0–40 µg/L and high as > 60).
Statistical analysis. We conducted anal-
yses with the menstrual cycle as the unit of
observation (Harlow and Zeger 1991).
Because of expected correlation within a
woman’s cycles, we fit mixed models that
account for repeated measures (Laird and
Ware 1982; Zeger and Liang 1986) with the
compound symmetry covariance structure
(assumes that all repeated units, e.g., cycles,
within a woman are equally correlated). We
calculated mean length and differences by
exposure level, as well as odds ratios (ORs) for
the risk of short or long length.
To identify potential confounders, we
examined numerous covariates, including
demographics, reproductive history, and
lifestyle factors, in relation to categorical
TTHM levels and the ingestion metric.
Smoking was calculated from the daily diary
as average cigarettes/day for each cycle
(Windham et al. 1999). All other variables
were obtained from the baseline interview.
Alcohol was calculated from frequency and
amount questions into drinks per week; and
caffeine was calculated from consumption of
coffee, tea, and sodas as milligrams per day
(Fenster et al. 1999a). Pregnancy history was
categorized as no pregnancy, at least one with
no losses, and at least one including one or
more losses. From questions on exercise type
and frequency, we calculated a measure of
energy expenditure, or metabolic equivalent
score. Variables associated with an end point or
with exposure [i.e., age, race, education,
income, employment, pregnancy history, body
mass index (BMI), exercise, smoking, caffeine
and alcohol consumption] were included in
models examining mean cycle length or the
odds of a short cycle. Each variable was
removed from the model individually to exam-
ine the change in estimate (Greenland 1989).
There was very little evidence of confounding
of the effects of TTHM level on mean cycle
length (all changes < 2%). The variable that
had the greatest confounding effect on the
association with short cycle was income (18%
change), with slight confounding (change in
estimate of 5–10%) by age, pregnancy history,
BMI, and caffeine and alcohol consumption.
These six variables, as well as race (because of a
strong association with the ingestion metric)
and smoking (associated with end point and
exposure), were included in all adjusted mod-
els for ease of presentation. However, as they
may not be confounders for all end points,
this could decrease the precision somewhat.
We calculated adjusted odds ratios (AORs)
and 95% confidence intervals (CIs) for the
categorical end points and adjusted differences
for mean lengths, by exposure level.
Results
Participants in the study were predominantly
white, parous, and educated, with a mean age
of 31 years (Table 1). Only 3% of women
had average TTHM levels above the MCL of
80 µg/L (or 4% of cycle-specific measures).
Categorical TTHM level varied by income
and, to a lesser extent, by race (Table 1).
Women with higher TTHM levels smoked
more and drank more caffeinated and alcoholic
beverages, on average. Amount of tap water
consumed and time spent showering did not
vary much by TTHM level (Table 1). Sixty-
three percent of women reported drinking at
least some unheated tap water at home, with
an average of about 2.3 glasses/day. Women
who exercised, were not employed, or drank
fewer caffeinated beverages were more likely to
report greater unheated tap water consumption
at home. Women who reported greater con-
sumption of beverages made from heated tap
water were generally older, as well as more
likely to have higher consumption of caffeine
(as might be expected), alcohol, and cigarettes.
Women who spent more time showering
tended to be younger and nonwhite.
Cycle characteristics by estimated TTHM
level and water consumption. The mean cycle
length was 28.8 days (SD 4.4), mean follicular
phase length was 16.0 days (SD 4.4), and
luteal phase length was 12.9 days (SD 1.7).
Examining cycle-specific utility-wide average
TTHM concentrations, we found a mono-
tonic decrease in mean cycle length with
increasing exposure category, so that the most
highly exposed cycles were more than 1 day
shorter after adjustment (Table 2). This
decrease was reflected as shorter follicular
phase length with increasing exposure, but lit-
tle difference in luteal phase or menses length
(Table 2). Unadjusted results were very similar
to adjusted, as were the results using the aver-
age exposure over all cycles, or examining only
ovulatory cycles. Cycles with TTHM levels
above the MCL were also shorter by about
1 day (β = –0.99; 95% CI, –2.2 to 0.18), with
an intermediate decrement of 0.7 days at the
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Table 2. Menstrual cycle parameters by cycle-specific utility-wide TTHM level: mean lengths and
adjusteda differences (95% CI).
Estimated TTHM level (µg/L)
Menstrual parameters 0–40 > 40–60 > 60
Cycle length
n 716 363 545
Meanb ± SE 29.7 ± 0.26 29.3 ± 0.28 28.7 ± 0.28
Adjusted difference (95% CI) Ref –0.50 (–1.1 to 0.11) –1.1 (–1.8 to –0.40)
Follicular phase length
n 676 337 501
Meanb ± SE 16.9 ± 0.27 16.5 ± 0.29 16.0 ± 0.30
Adjusted difference (95% CI) Ref –0.39 (–0.98 to 0.20) –0.94 (–1.6 to –0.24)
Luteal phase length
n 639 318 467
Meanb ± SE 12.9 ± 0.09 12.8 ± 0.11 13.0 ± 0.10
Adjusted difference (95% CI) Ref –0.08 (–0.33 to 0.18) 0.07 (–0.20 to 0.35)
Menses length
n 749 374 591
Meanb ± SE 5.3 ± 0.09 5.4 ± 0.09 5.3 ± 0.09
Adjusted difference (95% CI) Ref 0.09 (–0.12 to 0.30) –0.11(–0.34 to 0.12)
Ref, referent group.
aAdjusted for age, race, BMI, income, pregnancy history, smoking, and alcohol and caffeine consumption. bUnadjusted
means; ns were lower for adjusted models due to missing data.
middle category of > 40–80 µg/L (95% CI,
–1.3 to –0.10), compared with the lowest cat-
egory. Examining the estimated cycle-specific
TTHM concentration as a continuous vari-
able, we found a decrement in cycle length of
0.18 days per 10 µg/L increase (95% CI,
–0.29 to –0.07). The decrement in follicular
phase length was nearly identical, but there
was little difference in luteal phase or menses
lengths. Variability in the length of a woman’s
cycles did not appear associated with TTHM
level crudely or after adjustment. The range
(about 5 days, on average) was very similar
across TTHM categories, and the variance was
slightly greater in the low TTHM group (data
not shown).
By categorical end points, we found some
elevated risk of short cycle but little for short
follicular phase at the high TTHM level
(Table 3). We observed a reduced likelihood
of long cycles and especially long follicular
phases with increasing TTHM concentration
(Table 3). Using the > 80 µg/L cutoff instead
of > 60, a similar pattern for the reduced risk
of long length was observed; findings were
even slightly stronger for long follicular phase
(AOR 0.19; 95% CI, 0.07–0.55).
Mean cycle and phase lengths did not vary
much by categorized amount of unheated tap
water consumed at home (e.g., ± 0.25 days for
cycle length after adjustment). In contrast,
increasing consumption of heated tap water
was associated with decreased menstrual cycle
length; cycle and follicular phase lengths were
decreased by over 1 day with daily consump-
tion of three or more drinks made from
heated tap water (p = 0.05). Adjustment
reduced these differences, especially including
caffeine in the model; the decrement in cycle
length was 0.68 days for three or more heated
drinks (95% CI, –2.1 to 0.72).
Combining TTHM concentration and
unheated tap water consumption into an inges-
tion metric, we found a somewhat U-shaped
pattern with mean cycle length. The third cate-
gory (> 40–60 TTHM µg/day) had the shortest
mean cycle length (by 1 day), as well as some-
what reduced follicular and luteal phase lengths,
but the highest category (> 60 µg/day) showed
less difference (0.4 days for cycle length). Using
the ingestion metric based on total home tap
water consumption, we found the pattern of
reduced cycle length with increasing exposure
more consistent, showing an adjusted decre-
ment in mean cycle length of slightly greater
than 1 day at both of the two highest categories,
so we combined them into > 40 µg/day (Table
4). There was also a decrement in follicular
phase length of over 1 day (Table 4). The ORs
for the categorical end points showed the pat-
tern of decreased risk for long cycle and long
follicular phase with higher exposure, similar to
TTHM concentration alone.
Cycle characteristics by individual THM
levels. We examined whether one of the indi-
vidual THM compounds accounted for the
findings with TTHM levels. All brominated
compounds were associated with significantly
shorter cycles, but the strongest association
was with chlorodibromomethane; the
adjusted decrement in mean cycle length was
1.2 days at the highest quartile (Table 5).
Dose–response patterns were evident for each
brominated THM. As with the TTHM level,
these decrements were reflected as similar
decrements in follicular phase length.
Chloroform level was not associated with
much decrement in cycle length (Table 5),
but with a slight decrement in luteal phase
length of about 0.2 days at the highest quar-
tile (95% CI, –0.51 to 0.08). Menses length
varied little by any of the four compounds,
except for bromodichloromethane; menses
length was slightly longer at the high quartile
(β = 0.23; 95% CI, –0.01 to 0.47). Summing
the highly correlated brominated compounds,
we found monotonic dose–response patterns
of decreasing mean cycle length and follicular
phase length with increasing level (Table 5).
The odds of having a long cycle or long
follicular phase were strongly reduced at the
highest concentration of the summed bro-
minated compounds (AOR 0.55; 95% CI,
0.28–1.08 and AOR 0.26; 95% CI, 0.12–0.60,
respectively). This was fairly consistent for each
of the individual brominated compounds as
well. In addition, chloroform was associated
with an increased risk of short luteal phase
(AOR 2.2; 95% CI, 1.0–4.7) at the highest
quartile level.
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Table 3. Menstrual cycle parameters by cycle-specific utility-wide TTHM level: rates and AORa (95% CI).
Estimated TTHM level (µg/L)
Menstrual parameters 0–40 > 40–60 > 60
Total cycles (n)b 662 345 520
Short cycle (< 24 days)
Percent affected (n) 7.4 (49) 8.4 (29) 12.3 (64)
AOR (95% CI) Ref 0.95 (0.60–1.5) 1.5 (0.95–2.5)
Long cycle (> 36 days)
Percent affected (n) 8.1 (54) 5.4 (18) 5.2 (25)
AOR (95% CI) Ref 0.71 (0.44–1.1) 0.60 (0.31–1.1)
Short follicular phase (< 12 days)
Percent affected (n) 6.5 (41) 7.8 (25) 9.0 (44)
AOR (95% CI) Ref 0.95 (0.53–1.7) 1.2 (0.70–2.1)
Long follicular phase (> 24 days)
Percent affected (n) 7.6 (48) 5.1 (16) 3.1 (14)
AOR (95% CI) Ref 0.63 (0.36–1.1) 0.37 (0.18–0.76)
Short luteal phase (< 10 days)
Percent affected (n) 7.2 (39) 6.8 (18) 4.9 (19)
AOR (95% CI) Ref 0.94 (0.53–1.7) 0.56 (0.25–1.3)
Long menses (≥ 8 days)
Percent affected (n) 7.1 (48) 10.1 (34) 10.4 (55)
AOR (95% CI) Ref 1.6 (0.94–2.7) 1.3 (0.73–2.3)
Ref, referent group.
aAdjusted for age, race, BMI, income, pregnancy history, smoking, and alcohol and caffeine consumption. bTotal n for
unadjusted models of cycle length; denominators vary slightly for other parameters and are reduced slightly in adjusted
models because of missing data. Percent affected is calculated using these ns (e.g., unadjusted).
Table 4. Menstrual cycle parameters by cycle-specific utility-wide TTHM daily consumption level:a mean
lengths and adjustedb differences (95% CIs).
Estimated TTHM consumption level (µg/day)
Menstrual parameters 0 > 0–40 > 40
Cycle length
n 449 717 458
Mean ± SE 29.8 ± 0.39 29.4 ± 0.28 28.5 ± 0.33
Adjusted difference (CI) Ref –0.23 (–1.2 to 0.77) –1.1 (–2.2 to –0.06)
Follicular phase length
n 402 676 436
Mean ± SE 17.1 ± 0.43 16.6 ± 0.30 15.8 ± 0.34
Adjusted difference (CI) Ref –0.32 (–1.4 to 0.77) –1.1 (–2.2 to 0.03)
Luteal phase length
n 381 636 407
Mean ± SE 12.9 ± 0.13 12.9 ± 0.10 12.9 ± 0.12
Adjusted difference (CI) Ref –0.005 (–0.36 to 0.34) –0.08 (–0.46 to 0.29)
Menses length
n 462 759 493
Mean ± SE 5.4 ± 0.12 5.2 ± 0.09 5.4 ± 0.11
Adjusted difference (CI) Ref –0.31 (–0.63 to 0.01) –0.14 (–0.48 to 0.20)
Ref, referent group.
aUtility TTHM level (µg/L) × total home tap water consumption (glasses/day × 0.25 L/glass). bAdjusted for age, race, BMI,
income, pregnancy history, smoking, and alcohol and caffeine consumption.
Cycle characteristics by showering. The
crude mean cycle length varied little by time
spent showering (Table 6). After adjustment,
there was a tendency toward decreased length
with any category of showering above 35
min/week, which was stronger for follicular
phase than cycle length. However confidence
limits were wide. Examining the dummy vari-
able that incorporates TTHM level with
showering, the results appeared driven by the
high showering category; however, the num-
ber of cycles in the low showering and high
TTHM (> 60 µg/L) category was very small
(n = 82). The observed decrements had wide
CIs (high showering and high TTHM: for
cycle length, β = –1.2 days; 95% CI, –3.6 to
1.1, and for follicular phase length, β = –1.6;
95% CI, –4.2 to 1.1).
Discussion
We found a consistent reduction in menstrual
cycle length, and a corresponding reduction in
follicular but not luteal phase length, with
greater estimated exposure to chlorination by-
products as calculated in a number of ways.
We observed a monotonic dose–response
effect for the total trihalomethane concentra-
tion based on utility-wide measurements. A
decrement in mean cycle length of about 1
day was seen at the level corresponding to the
current U.S. EPA MCL of > 80 µg/L and sim-
ilar to the level we examined in our previous
studies (Waller et al. 1998a, 2001), as well as
at the even lower level of > 60 µg/L. These
findings were strengthened by a significant
decrement in length with increasing bromi-
nated THM concentration and with TTHM
as a continuous measure. Furthermore, there
was a reduction in the odds of long cycles or
long follicular phases at the high total and
brominated THM category. An association
with the brominated THMs is consistent with
our previous study (Waller et al. 1998a). If
causal, this could influence differences
between study findings, as the proportion of
TTHM represented by brominated com-
pounds varies by water system dependent on
the type of organic material present.
Attempts to quantify amount of exposure
based on individual water use patterns, such as
tap water consumption or showering, did not
strengthen the effects greatly, but did show
consistent patterns of decreased cycle length
with increasing exposure for the ingestion met-
rics. The ingestion metric with total tap water
showed a more consistent pattern than with
unheated tap water alone, similar to another
study (Klotz and Pyrch 1999). As THMs
would volatilize out of heated water, this may
implicate an additional compound(s). The
associations may not have been strengthened
by water use patterns because other sources of
exposure are not accounted for, such as wash-
ing, cooking, and housecleaning, as well as
exposures outside the home, leading to further
misclassification (see below).
No other studies of chlorination by-prod-
ucts have examined menstrual cycle function,
but as noted earlier, several studies have found
increased risks of adverse pregnancy outcomes
at higher exposure levels (Bove et al. 1995;
Dodds et al. 1999; Gallagher et al. 1998;
Kramer et al. 1992; Nieuwenhuijsen et al.
2000; Savitz et al. 1995; Waller et al. 1998a).
An effect on the hypothalamic–pituitary system
that controls hormone secretion could be an
underlying mechanism leading to multiple
effects on both pregnancy and ovarian function.
Animal experiments have shown exogenous
exposures that act on the central nervous system
can affect ovulation (Stoker et al. 2001). An
increase in fetal resorptions in rats exposed to
bromoform and bromodichloromethane, as
well as changes in hormone levels indicating
disruption of the pituitary–gonadal axis
(Bielmeier et al. 2001), further supports this
hypothesis.
Our finding of a shortened menstrual cycle
during the follicular phase indicates an alter-
ation in menstrual cycle function and presum-
ably ovarian function. A shorter follicular
phase reflects earlier ovulation, potentially
affecting oocyte maturation, endometrial
thickening, and conception or contraception
timing. Postovulatory aging at the time of con-
ception has been associated with an increased
risk of early pregnancy loss (Wilcox et al.
1998). Clinical studies have found lower con-
ception rates associated with short follicular
phase (Check et al. 1992; Liss et al. 2002) and
an epidemiologic study found lower fecundity
with short (and more variable) cycle length
(Kolstad et al. 1999). A shorter cycle length has
also been associated with an earlier age at
menopause (Whelan et al. 1990), perhaps
reflecting follicle depletion and ovarian aging,
and an increased risk of breast cancer (Kelsey
et al. 1993).
Our previous findings (Fenster et al.
1999a; Windham et al. 1999) with respect to
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Table 5. Means and adjusteda differences (95% CIs) in menstrual cycle and follicular phase length by
quartilesb of individual THM compounds.
Quartileb of exposure
1c 2–3 4
Menstrual characteristics Mean in days ± SE Difference (95% CI) Difference (95% CI)
Cycle length
Bromoform 29.7 ± 0.26 –0.42 (–0.96 to 0.13) –0.79 (–1.4 to –0.14)
Bromodichloromethane 29.8 ± 0.30 –0.59 (–1.2 to –0.02) –0.74 (–1.5 to –0.02)
Chlorodibromomethane 30.0 ± 0.33 –0.69 (–1.4 to –0.02) –1.2 (–2.0 to –0.38)
Chloroform 29.6 ± 0.30 –0.43 (–0.99 to 0.13) –0.30 (–1.0 to 0.40)
Sum of brominated 30.0 ± 0.34 –0.72 (–1.4 to –0.04) –1.2 (–2.0 to –0.40)
Follicular phase length
Bromoform 16.9 ± 0.27 –0.30 (–0.83 to 0.23) –0.78 (–1.4 to –0.14)
Bromodichloromethane 17.0 ± 0.31 –0.54 (–1.1 to 0.01) –0.80 (–1.5 to –0.08)
Chlorodibromomethane 17.1 ± 0.34 –0.62 (–1.3 to 0.05) –1.1 (–1.9 to –0.25)
Chloroform 16.8 ± 0.31 –0.42 (–0.96 to 0.12) –0.13 (–0.82 to 0.56)
Sum of brominated 17.2 ± 0.35 –0.66 (–1.3 to 0.02) –1.1 (–1.9 to –0.29)
aAdjusted for age, race, BMI, income, pregnancy history, caffeine and alcohol consumption, and smoking. bTop quartiles
for each compound and the summed brominated are: ≥ 12, ≥ 16, ≥ 20, ≥ 17, and ≥ 45 µg/L, respectively. cReference group;
the mean provided is unadjusted with SE.
Table 6. Menstrual cycle parameters by time spent showering: mean lengths and adjusteda differences
with 95% CIs.
Shower time (minutes/week)
Menstrual parameters 0–34 35–69 70–104 ≥ 105
Cycle length
n 305 499 471 307
Meanb ± SE 29.3 ± 0.46 29.0 ± 0.37 29.6 ± 0.38 29.1 ± 0.47
Adjusted difference (CI) Ref –0.70 (–1.9 to 0.47) –0.47 (–1.7 to 0.74) –0.68 (–2.0 to 0.62)
Follicular phase length
n 291 459 437 287
Meanb ± SE 16.8 ± 0.51 16.2 ± 0.40 16.8 ± 0.41 16.3 ± 0.50
Adjusted difference (CI) Ref –1.1 (–2.3 to 0.22) –0.90 (–2.2 to 0.42) –1.2 (–2.6 to 0.26)
Luteal phase length
n 273 428 414 270
Meanb ± SE 12.8 ± 0.16 12.9 ± 0.12 13.0 ± 0.13 12.9 ± 0.16
Adjusted difference (CI) Ref 0.03 (–0.37 to 0.43) 0.11 (–0.30 to 0.52) 0.18 (–0.26 to 0.63)
Menses length
n 330 534 483 319
Meanb ± SE 5.3 ± 0.15 5.5 ± 0.12 5.2 ± 0.12 5.2 ± 0.15
Adjusted difference (CI) Ref 0.26 (–0.12 to 0.63) –0.004 (–0.39 to 0.38) –0.06 (–0.48 to 0.36)
Ref, referent group.
aAdjusted for age, race, BMI, income, pregnancy history, smoking, and alcohol and caffeine consumption. bUnadjusted
means (n corresponds to these).
exogenous exposures in this data set indicated
an increased risk (2–3 times) of short cycle
with greater exposure to tobacco smoke or caf-
feine, which translated to reductions in cycle
length of 2.5 and 0.4 days, respectively. These
variables were controlled for in this analysis, as
were several other variables potentially associ-
ated with menstrual function. Mean cycle
length is known to vary by age, but little is
known about other predictors of cycle length.
Some factors that we as well as others have sug-
gested include race, body size, exercise, and
stress (Fenster et al. 1999b; Harlow and
Ephross 1995; Waller et al. 1998b). We found
little evidence for confounding in this analysis.
Nutrition may be related to menstrual cycle
function, but we did not collect data on this
factor, and this population of HMO members
is unlikely to have severe nutritional deficien-
cies. More subtle effects on the endocrine sys-
tem and menstrual cycling from consumption
of foods containing hormonelike substances
have also been suggested (Cassidy et al. 1994).
However, for these foods to represent con-
founding factors, their consumption would
have to vary with TTHM level. Other environ-
mental exposures have been associated with
changes in cycle length of a similar magnitude
to this study, including 1 day shorter with
higher estimated PCB exposure (Mendola et
al. 1997) and 1 day longer with premenarcheal
dioxin exposure (Eskenazi et al. 2002).
One concern in all studies of chlorination
by-products is exposure misclassification;
nearly all studies of reproductive outcomes
have used existing water treatment records.
Our estimation of THM level was more spe-
cific than some because it is based on actual
utility measurements (vs. water source or type
of treatment) within a relatively narrow time
frame around the cycle start date (vs. an annual
average, for example) and incorporating per-
sonal water use. Based on our previous work
that compared different statistical methods for
using water utility data, calculating the utility-
wide average TTHM level provided a reason-
able, efficient estimate (Waller et al. 2001).
However, the utility measurements are made at
only selected points within the distribution sys-
tem and will differ from what actually comes
out of an individual tap on any given day.
Another source of misclassification may be the
self-reported quantification of everyday habits
involving exposure, as well as the lack of data
collection on other sources of exposure, includ-
ing those outside the home. This misclassifica-
tion would be most likely to attenuate results.
Conducting a type of sensitivity analysis, we
found the results varied somewhat by the defi-
nition of the exposure time period; similar
results were also seen for a period 90 days
before the cycle start date and using the overall
average of a woman’s cycle-specific TTHM
levels. The results were attenuated for a period
starting 30 days before and extending 60 days
after the cycle start date, perhaps reflecting
greater misclassification, as some measurements
could occur after the cycle is over. Misclassifi-
cation of the end points, particularly cycle
length, is less likely, and our mean lengths are
well within the range of other studies (Harlow
and Ephross 1995). The day of ovulation,
which determines the follicular phase length, is
estimated from urinary hormone patterns so
may vary by a day or two from actual ovulation
(Baird et al. 1990). However, this is likely to be
random with respect to TTHM level.
The study sample is not representative of
the general population; because of the labor-
intensive nature of data collection, only about
40% of initially eligible women completed
the study. This rate is similar to other studies
with similar methods, despite both recruiting
from occupational cohorts (Gold et al. 1995)
and one for a shorter urine collection period
(Whelan et al. 2002). As noted, all partici-
pants were English-speaking and tended to be
well educated. In addition, the most extreme
abnormalities of cycle function would not be
included because of some of the eligibility
requirements designed to increase the likeli-
hood of pregnancy, and because the more
normal or typical hormone patterns were
included when duplicate assays were discor-
dant. Nevertheless, the consumption, or
exposure, patterns with respect to tap water
and THMs were similar to our earlier studies
(Swan et al. 1992, 1998; Waller et al. 1998a;
Windham et al. 1992).
This study has many strengths, including its
prospective design. Because women were not
selected because of pregnancy or an adverse
outcome, their reported consumption should
have been representative of their usual patterns.
The estimated TTHM level was ascertained
independently using existing records and the
woman’s address, as well as some measures of
personal water use. The menstrual parameters
were based on biologic measures (e.g., the hor-
mone levels) rather than self-reporting, col-
lected over several cycles per participant,
providing a large improvement over studies that
ask for usual cycle length or subjective men-
strual symptoms. Furthermore, many potential
confounders were considered in these analyses.
Because this is the first study to report
such findings, it will be important to confirm
them. They add to the growing literature
indicating effects of exposure to chlorination
by-products on reproduction and expand it to
include ovarian function.
REFERENCES
Baird DD, Weinberg CR, Wilcox AJ, McConnaughey DR, Musey
PI. 1990. Using the ratio of urinary estrogen and proges-
terone metabolites to estimate day of ovulation. Stat Med
10:255–266.
Bielmeier SR, Best DS, Guidici DL, Narotsky MG. 2001. Pregnancy
loss in the rat caused by bromodichloromethane. Toxicol Sci
59:309–315.
Bove FJ, Fulcomer MC, Klotz JB, Esmart J, Dufficy EM, Savrin
JE. 1995. Public drinking water contamination and birth
outcomes. Am J Epidemiol 141:850–862.
Cassidy A, Bingham S, Setchell KDR. 1994. Biological effects of a
diet of soy protein rich in isoflavones on the menstrual cycle
of premenopausal women. Am J Clin Nutr 60:333–340.
Check JH, Adelson H, Lurie D, Jamison T. 1992. Effect of short
follicular phase on subsequent conception. Gynecol Obstet
Invest 34:180–183.
Dodds L, King W. 2001. Relation between trihalomethane com-
pounds and birth defects. Occup Environ Med 58:443–446.
Dodds L, King W, Woolcott C, Pole J. 1999. Trihalomethanes in
public water supplies and adverse birth outcomes.
Epidemiology 10:233–237.
Eskenazi B, Warner M, Mocarelli P, Samuels S, Needham LL,
Patterson DG, et al. 2002. Serum dioxin concentrations
and menstrual cycle characteristics. Am J Epidemiol
156:383–392.
Fenster L, Quale C, Waller K, Windham GC, Elkin EP, Benowitz N,
et al. 1999a. Caffeine consumption and menstrual function.
Am J Epidemiol 149:550–557.
Fenster L, Waller K, Chen J, Hubbard AE, Windham GC, Elkin E,
et al. 1999b. Psychological stress in the workplace and
menstrual function. Am J Epidemiol 149:127–134.
Gallagher MD, Nuckols JR, Stallones L, Savitz D. 1998. Exposure
to trihalomethanes and adverse pregnancy outcomes.
Epidemiology 9:484–489.
Gold EB, Eskenazi B, Lasley BL, Samuels SJ, Rasor MO,
Overstreet JW, et al. 1995. Epidemiologic methods for
prospective assessment of menstrual cycle and reproduc-
tive characteristics of female semi-conductor workers. Am
J Ind Med 28:783–797.
Greenland S. 1989. Modeling and variable selection in epidemi-
ologic analysis. Am J Public Health 79:340–349.
Harlow SD, Ephross SA. 1995. Epidemiology of menstruation
and its relevance to women’s health. Epidemiol Rev
17:265–286.
Harlow SD, Zeger SL. 1991. An application of longitudinal meth-
ods to the analysis of menstrual diary data. J Clin Epidemiol
44:1015–1025.
Kassam A, Overstreet JB, Snow-Harter C, De Souza MG, Gold EB,
Lasley BL. 1996. Identification of anovulation and transient
luteal function using a urinary pregnanediol-3-glucuronide
ratio algorithm. Environ Health Perspect 104:408–413.
Kelsey JL, Gammon MD, John EM. 1993. Reproductive factors
and breast cancer. Epidemiol Rev 15:36–47.
King WD, Dodds L, Allen AC. 2000. Relation between stillbirth
and specific chlorination by-products in public water sup-
plies. Environ Health Perspect 108:883–886.
Klotz JB, Pyrch LA. 1999. Neural tube defects and drinking water
disinfection byproducts. Epidemiology 10:383–390.
Kolstad HA, Bonde JP, Hjollund NH, Jensen TK, Henriksen TB,
Ernst E, et al. 1999. Menstrual cycle pattern and fertility: a
prospective follow-up study of pregnancy and early
embryonal loss in 295 couples who were planning their
first pregnancy. Fertil Steril 71:490–496.
Kramer MD, Lynch CF, Isacson P, Hanson JW. 1992. The associ-
ation of waterborne chloroform with intrauterine growth
retardation. Epidemiology 3:407–413.
Laird N, Ware J. 1982. Random effects models for longitudinal
data. Biometrics 38:963–974.
Liss JR, Check JH, Shucoski K, Check ML. 2002. Effect of short
follicular phase on conception outcome [Abstract]. Fertil
Steril 77:S17.
Mendola P, Buck GM, Sever LE, Zielezny M, Vena JE. 1997.
Consumption of PCB-contaminated freshwater fish and
shortened menstrual cycle length. Am J Epidemiol
146:955–960.
Munro CJ, Stabenfeldt GH, Cragun JR, Addiego LA, Overstreet
JW, Lasley BL. 1991. Relationship of serum estradiol and
progesterone concentrations to the excretion profiles of
their major urinary metabolites as measured by enzyme
immunoassay and radioimmunoassay. Clin Chem 37:838–844.
Neutra RR, Swan SH, Hertz-Picciotto I, Windham GC, Wrensch
M, Shaw GM, et al. 1992. Potential sources of bias and
confounding in environmental epidemiologic studies of
pregnancy outcome. Epidemiology 3:134–142.
Nieuwenhuijsen MJ, Toledano MB, Eaton NE, Fawell J, Elliott P.
2000. Chlorination disinfection byproducts in water and their
association with adverse reproductive outcomes: a review.
Occup Environ Med 57:73–85.
Reif JS, Hatch MC, Bracken M, Holmes LB, Schwetz BA,
Environmental Medicine | Windham et al.
940 VOLUME 111 | NUMBER 7 | June 2003 • Environmental Health Perspectives
Singer PC. 1996. Reproductive and developmental effects
of disinfection by-products in drinking water. Environ
Health Perspect 104:1056–1061.
Savitz DA, Andrews KW, Pastore LM. 1995. Drinking water and
pregnancy outcome in central North Carolina: source,
amount and trihalomethane levels. Environ Health Perspect
103:592–596.
Stoker TC, Goldman JM, Cooper RL. 2001. Delayed ovulation and
pregnancy outcome: effect of environmental toxicants on
the neuroendocrine control of the ovary. Environ Toxicol
Pharmacol 9:117–129.
Swan SH, Neutra RR, Wrensch M, Hertz-Picciotto I, Windham
GC, Fenster L, et al. 1992. Is drinking water related to
spontaneous abortion? Reviewing the evidence from the
California Department of Health Services Studies.
Epidemiology 3:83–93.
Swan SH, Waller K, Hopkins B, Windham G, Fenster L, Schaefer
C, Neutra RR. 1998. A prospective study of spontaneous
abortion: relation to amount and source of drinking water
consumed in early pregnancy. Epidemiology 9:126–133.
Waller K, Swan SH, DeLorenze G, Hopkins B. 1998a. Trihalo-
methanes in drinking water and spontaneous abortion.
Epidemiology 9:134–140.
Waller K, Swan SH, Windham GC, Fenster L, Elkin EP, Lasley BL.
1998b. Use of urine biomarkers to evaluate menstrual func-
tion in healthy premenopausal women. Am J Epidemiol
147:1071–1080.
Waller K, Swan SH, Windham GC, Fenster L. 2001. Influence of
exposure assessment methods on risk estimates in an epi-
demiologic study of total trihalomethane exposure and
spontaneous abortion. J Expo Anal Environ Epidemiol
11:522–531.
Whelan EA, Grajewski B, Wood E, Kwan L, Nguyen M, Schnorr
T, et al. 2002. Feasibility issues in reproductive biomonitor-
ing of female flight attendants and teachers. J Occup
Environ Med 44:947–955.
Whelan EA, Sandler DP, McConnaughey DR, Weinberg CR.
1990. Menstrual and reproductive characteristics and age
at natural menopause. Am J Epidemiol 131:625–632.
Wilcox AJ, Weinberg CR, Baird DD. 1998. Post-ovulatory aging
of the human ovum and embryo failure. Hum Reprod
14:1835–1839.
Windham GC, Elkin EP, Fenster L, Waller K, Anderson M, Mitchell
PR, et al. 2002. Ovarian hormones in premenopausal women:
variation by demographic, reproductive and menstrual cycle
characteristics. Epidemiology 13:675–684.
Windham GC, Elkin EP, Swan SH, Waller KO, Fenster L. 1999.
Cigarette smoking and effects on menstrual function. Obstet
Gynecol 93:59–65.
Windham GC, Swan SH, Fenster L, Neutra RR. 1992. Tap or bot-
tled water consumption and spontaneous abortion: a 1986
case-control study in California. Epidemiology 3:113–119.
Zeger S, Liang KY. 1986. Longitudinal data analysis for discrete
and continuous outcomes. Biometrics 42:121–130.
Environmental Medicine | Chlorination by-products and menstrual cycle function
Environmental Health Perspectives • VOLUME 111 | NUMBER 7 | June 2003 941
